TRAW vs XRAY · rev $2.8M vs rev $1.78B
Traws Pharma Inc (TRAW) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
TRAW currently screens at market cap $12.1M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the TRAW and XRAY stock pages for the full models.
Not investment advice.